Who
Lucas Montarce
EVP & CFO
Company insider
Files Form 4 as: EVP & CFO, Eli Lilly and.
In numbers
- Trades disclosed
- 16
- Buys
- 1
- Sells
- 0
- Bought
- $495K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Nov 2024
- Last trade
- 1 Nov 2026
- Last filed
- 3 Nov 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Nov 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Nov 2026filed 3 Nov 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —1,610 at $0.00 | filing |
| 1 Nov 2026filed 3 Nov 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $961K677.593 at $1,417.54 | filing |
| 1 Nov 2026filed 3 Nov 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,610 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —368 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $166K159.733 at $1,040.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —368 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —368 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —368 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $166K159.73 at $1,040.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1.4M1,365.47 at $1,044.67 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $1.4M1,365.47 at $1,044.67 | filing |
| 15 Aug 2025filed 15 Aug 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Bought | $495K715 at $691.79 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $2.5M2,895.93 at $868.88 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,074 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —1,074 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $383K467.2 at $818.93 | filing |
News
Eli Lilly and Company (NYSE:LLY) EVP Anat Hakim Sells 5,000 Shares of Company StockLLY · themarketsdaily.com · 3 Nov 2026450 Eli Lilly and Company $LLY Shares Purchased by Vigilare Wealth ManagementLLY · dailypolitical.com · 3 Nov 2026Trek Financial LLC Buys 380 Shares of Eli Lilly and Company $LLYLLY · dailypolitical.com · 3 Nov 2026
0 headlines in the last 90 days name Lucas Montarce; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.